Zlatko Trajanoski

25PUBLICATIONS
181CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jul 31, 2026
A transcriptional signature of resting mast cells is associated with improved disease outcome in HR+HER2- breast cancer.

|May 27, 2026
DUSP1 is a key driver of disease persistence and potential therapeutic target in hairy cell leukemia.

|Feb 27, 2026
NR2F6 deletion revives CAR-T cell function and induces antigen-agnostic immune memory in solid tumors.

Dominik Humer, Victoria Klepsch, Dietmar Rieder

|Jul 23, 2025
Author Correction: IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2- breast cancer via CX3CR1+ macrophages.

Giulia Petroni, Claudia Galassi, Kenneth H Gouin

|Jul 07, 2025
IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2- breast cancer via CX3CR1+ macrophages.

Giulia Petroni, Claudia Galassi, Kenneth H Gouin

|May 30, 2025
IL-36 signaling as a drug target in Crohn's disease patients with IL36RN mutations.

Julia Hecker, Christina Plattner, Camila A Cancino

Pageof 5

Frequent Collaborators

6 joint publications

Francesca Finotello

5 joint publications

Gregor Sturm

5 joint publications

Dietmar Rieder

4 joint publications

Alexander Kirchmair